Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial by Kennedy, Glen A, MBBS, Varelias, Antiopi, PhD, Vuckovic, Slavica, PhD, Le Texier, Laetitia, PhD, Gartlan, Kate H, PhD, Zhang, Ping, MD, Thomas, Gethin, PhD, Anderson, Lisa, BBiomedSc, Boyle, Glen, PhD, Cloonan, Nicole, PhD, Leach, Justine, BN, Sturgeon, Elise, BN, Avery, Judy, BHlthSc, Olver, Stuart D, BSc, Lor, Mary, BSc, Misra, Ashish K, MBBS, Hutchins, Cheryl, PhD, Morton, A James, MBBS, Durrant, Simon TS, MBBS, Subramoniapillai, Elango, MBBS, Butler, Jason P, MMedSci, Curley, Cameron I, MBBS, MacDonald, Kelli P A, PhD, Tey, Siok-Keen, MBBS, Hill, Geoffrey R, Prof

Get full text